Webinar presentation: Information session on the revised evidence guidelines for listed medicines, 23 March 2022
Disclaimer
These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: : Diane Wilkinson - Therapeutic Goods Administration
- Presented at: Online webinar
- Presentation date: Wednesday 23 March 2022
- Presentation summary: The TGA providing an overview of the revised evidence guidelines for listed medicines.
Related content
-
Future regulation of assistive technologies information session
Hear about the options we currently considering in relation to the future regulation of assistive technologies. Q and A session included. -
Updates to the medical device post-market review compliance dashboard for exempt vape devices and accessories
View the proposed changes to the post-market review compliance portal allowing sponsors of exempt devices to view and respond to regulatory notices, and ask questions and provide feedback on the proposed changes. -
Consent to supply vape devices and accessories that do not comply with the Essential Principles - an opportunity to provide feedback
View the proposed changes to the on-line application form for consent to import, export, or supply medical devices that do not comply with the Essential Principles.
This webpage on the TGA website was printed on 18 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/event/webinars/webinar-presentation-information-session-revised-evidence-guidelines-listed-medicines-23-march-2022